Greg Ryslik - Compass Pathways Engineering, AI
| CMPS Stock | USD 6.85 0.04 0.58% |
Insider
Greg Ryslik is Engineering, AI of Compass Pathways Plc
| Address | 33 Broadwick Street, London, United Kingdom, W1F 0DQ |
| Phone | 44 71 6676 6461 |
| Web | https://compasspathways.com |
Compass Pathways Management Efficiency
The company has return on total asset (ROA) of (0.3843) % which means that it has lost $0.3843 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.0581) %, meaning that it created substantial loss on money invested by shareholders. Compass Pathways' management efficiency ratios could be used to measure how well Compass Pathways manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.76 in 2025. Return On Capital Employed is likely to drop to -1.04 in 2025. At this time, Compass Pathways' Other Current Assets are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 6.2 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 135.8 M in 2025.Similar Executives
| Showing other executives | INSIDER Age | ||
| Shubham Maheshwari | Varex Imaging Corp | 54 | |
| Thomas MBA | Kalvista Pharmaceuticals | 49 | |
| Jason Johnson | Community Health Systems | 51 | |
| Erin Boyd | Talkspace | 56 | |
| Gil Margolin | Talkspace | 47 | |
| K Krishnan | Community Health Systems | 64 | |
| Jeremy Falke | Sonida Senior Living | 51 | |
| S Mansbach | Avanos Medical | N/A | |
| Michelle Scharfenberg | Avanos Medical | N/A | |
| Richard MD | Gossamer Bio | 65 | |
| PT MBA | Enhabit | N/A | |
| Hideki MD | Prothena plc | 59 | |
| Katelyn Watson | Talkspace | 46 | |
| MD MBA | Kalvista Pharmaceuticals | 53 | |
| Tran MBA | Prothena plc | 51 | |
| Robert Hollister | Sonida Senior Living | 64 | |
| Mike Zanoni | 4D Molecular Therapeutics | N/A | |
| Jill Krueger | Sonida Senior Living | 60 | |
| Austen Mason | Community Health Systems | 34 | |
| David Brickman | Sonida Senior Living | 66 | |
| H Williams | Community Health Systems | 66 | |
Management Performance
| Return On Equity | -2.06 | ||||
| Return On Asset | -0.38 |
Compass Pathways Plc Leadership Team
Elected by the shareholders, the Compass Pathways' board of directors comprises two types of representatives: Compass Pathways inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Compass. The board's role is to monitor Compass Pathways' management team and ensure that shareholders' interests are well served. Compass Pathways' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Compass Pathways' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Teri MBA, Principal CFO | ||
| Guy Goodwin, Chief Officer | ||
| Trevor Mill, Chief Officer | ||
| Christopher Williams, Chief Officer | ||
| Lori MBA, Chief Officer | ||
| MBA MA, Chief Officer | ||
| Anne Benedict, Chief Officer | ||
| Ekaterina MD, CoFounder Director | ||
| Lars Wilde, Senior Advisor | ||
| Susan Stansfield, Advisor | ||
| George Goldsmith, Chairman Cofounder | ||
| Michael Falvey, Chief Officer | ||
| MaryRose Hughes, Principal CFO | ||
| Greg Ryslik, Engineering, AI | ||
| Stephen Schultz, Senior Relations | ||
| Benjamin Harber, Company Secretary | ||
| Matthew Owens, General Officer | ||
| MSc MD, Chief Officer | ||
| Steve MD, Chief Officer |
Compass Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Compass Pathways a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.06 | ||||
| Return On Asset | -0.38 | ||||
| Current Valuation | 506.48 M | ||||
| Shares Outstanding | 96.02 M | ||||
| Shares Owned By Insiders | 12.12 % | ||||
| Shares Owned By Institutions | 61.84 % | ||||
| Number Of Shares Shorted | 5.58 M | ||||
| Price To Book | 17.48 X | ||||
| EBITDA | (148.82 M) | ||||
| Net Income | (155.12 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Compass Stock Analysis
When running Compass Pathways' price analysis, check to measure Compass Pathways' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Pathways is operating at the current time. Most of Compass Pathways' value examination focuses on studying past and present price action to predict the probability of Compass Pathways' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Pathways' price. Additionally, you may evaluate how the addition of Compass Pathways to your portfolios can decrease your overall portfolio volatility.